Drug Type Universal CAR-T |
Synonyms KJ C2114, KJC2114 |
Target- |
Action- |
Mechanism Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | China | 04 Mar 2022 |





